Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. - Wikidata - wikimedia - TriplyDB

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

http://www.wikidata.org/entity/Q43038794

about

Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact The cancer stem cell: evidence for its origin as an injured autoreactive T cell Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Extrahepatic manifestations of chronic hepatitis C virus infection Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls Hepatitis C virus and lymphoma Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia Antibody-Dependent Enhancement of Hepatitis C Virus Infection Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection.Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma.Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Secondary cutaneous marginal zone B-cell lymphoma presenting as lipoatrophy in a patient with hepatitis C Review.Hepatitis C virus-related lymphoproliferative disorders: an overview.Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.Lymphoid malignancies: the dark side of B-cell differentiation.microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus B-cell receptor signaling as a driver of lymphoma development and evolution.Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.Human viruses and cancer.Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia Primary spleen lymphoma associated with hepatitis C virus infection

P2860

Q22299128-6D21B31B-297E-4D63-82A9-5172A172C4DF Q25256839-607CEDC4-F18C-4804-A887-84B7C832F638 Q26750997-41D6C493-D7D7-45FC-B5EB-3EB2A63A3C4C Q26767084-3806F3A6-C56F-4593-A477-2D172394F4F5 Q26770344-01CEE92D-1302-426F-9373-F5926AC4F98B Q26775007-D5603F1D-9BCE-42DB-AA0A-CCCE6205F74A Q26775733-0EC4783B-F99B-40E3-80BF-01B7E7E89792 Q26781743-ACBC4FA6-83BB-40C1-B578-DBCDF9CCFDF3 Q27023448-0AC28AED-3CFC-40C2-A2C8-42E65BB21BD2 Q27473390-E40992A0-6054-4568-8FD5-01B3D941B2B5 Q27480341-D32C9644-069D-47B5-A616-4B59BB272E47 Q27482007-547100AA-2A16-4845-9013-E1E2F560CB20 Q27485227-2D4708D3-E101-4318-9984-E27EE4B782C8 Q27485451-E85225A1-11B9-4E94-A8FE-85A3AD1B4311 Q27486411-531584C5-4F34-4759-A9D4-2FDDB1119580 Q28069401-C5163DAC-B5A9-429C-A61A-89DAD2B41049 Q28080160-982FB4D8-6FA8-4B6A-A247-2D73CF3B24E2 Q30251847-669CFA16-DDF4-49D5-BA83-96F3B89B935F Q31154023-20BF9463-C19A-4FFE-A5E4-555AABBD4394 Q33346756-8B8707B8-0719-401F-BD55-3A463F4F52A4 Q33415564-ECDB57B7-799F-434A-8E0F-FC6452674A72 Q33418199-DE89DC93-9105-4BCF-A01B-3702C4A57C7E Q33587826-55B9E12A-F830-484F-9429-E38B670439DD Q33634440-A9772B79-CC6E-4BD5-A71B-B3E7D3D99C8A Q33883727-808A6BB7-CB0F-4947-95AC-F34E4F43F454 Q33889168-D4A738C9-F85F-43A7-875F-8C496DEBB6B9 Q33890865-5CA9B5AC-02AF-4DF5-9DDE-0CBED654272A Q34062040-526B51CE-CEBF-4976-871C-D5F7B2BA9E7E Q34098553-D58CCB4A-3796-43C0-84C1-1ABA07474C18 Q34102077-5AD4C04C-0E5C-4841-A035-C5779B155C09 Q34162187-E385184E-042F-4F74-AC31-674D023C7EE4 Q34163429-F92BE3A2-EEBD-4C52-9A13-530715183A32 Q34398579-5956EC41-5FA1-4F32-9722-28E57E50190E Q34420891-67CA9E30-0C32-43B4-98D3-BF673EE370F7 Q34423461-25F410C9-6D69-4E09-8B3C-2F226600B852 Q34521334-A0361C7F-CA98-4BFC-AB00-0D40C5EB44BC Q34542102-69CB902F-B174-491C-B456-616DDF7C96F4 Q34552105-54FB7754-DC0F-4808-B6CE-78923C3A8F94 Q34708468-641F4EC1-FB40-4067-A601-2C258C897CFE Q34710617-5914486E-9F20-4C91-BCA8-3AB8E568E616

P2860

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

http://www.wikidata.org/entity/Q43038794

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@en

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@nl

type

label

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@en

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@nl

prefLabel

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@en

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@nl

P1433

Q43038794-DD2CAFE2-52F8-45F4-AF14-44018F32F45A

P1476

Q43038794-933E008E-2FA1-4173-83E0-8D52D2D00DAE

P2093

Q43038794-0293F157-C1B4-4F8F-813E-94309EC14E05

Q43038794-10FD2EEB-A72B-4624-829B-173391A1A7F2

Q43038794-167444EC-6988-4DD2-A392-1440FF33E3FE

Q43038794-3177AA4B-1F7C-4E33-A6CC-4F6D6A9E170F

Q43038794-7B91E3B6-A8B8-4A42-A2DA-15258A175EE8

Q43038794-A5FA02E3-B8CF-43C4-8BBD-A7275A60C1BE

Q43038794-E30BC693-690A-4175-87CD-29F5F6966C2E

Q43038794-E3FA8DC9-91AE-4554-9B24-77E33E7BFB13

Q43038794-E77C04AB-7831-4993-A947-B682F72DE17B

Q43038794-EE5CB53F-A902-4621-8B13-C1A2785CF1ED

P304

Q43038794-772D4A8C-7EEB-4D43-B44B-3937D53B746E

P31

Q43038794-B2F8AFAD-A458-4A9A-B4D6-C2FC783F21E6

P356

Q43038794-5EFE915D-CDA2-4890-95C0-DA193CB551B7

P407

Q43038794-51B0E37D-45C9-4DEB-9B79-99FAC11D1C48

P433

Q43038794-681316F2-960B-49D1-A6A9-3D37157D6012

P478

Q43038794-28E270A5-4B45-429D-8B76-33745F13E3F5

P50

Q43038794-D5E14436-882C-407E-BC52-6535AA00232F

Q43038794-E219C1BE-D728-430B-B508-BA00F51D539D

P577

Q43038794-4B987B06-15AE-4D12-8F1C-EF2A0C9FFEF1

P5875

Q43038794-1FBBDB5B-CCEA-450F-BE69-CBD9DEBFDCE2

P698

Q43038794-BE9DE12B-6443-4DD7-B2A3-961E12B10423

P356

P1433

The New England Journal of Medicine

P1476

Regression of splenic lymphoma ...... f hepatitis C virus infection.

@en

P2093

Bruno Varet

http://www.w3.org/2001/XMLSchema#string

Béatrice Delmas

http://www.w3.org/2001/XMLSchema#string

Christian Brechot

http://www.w3.org/2001/XMLSchema#string

François Lefrère

http://www.w3.org/2001/XMLSchema#string

Françoise Valensi

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Bronowicki

http://www.w3.org/2001/XMLSchema#string

Katayoun Jondeau

http://www.w3.org/2001/XMLSchema#string

Virginie Eclache-Saudreau

http://www.w3.org/2001/XMLSchema#string

Xavier Mariette

http://www.w3.org/2001/XMLSchema#string

Xavier Troussard

http://www.w3.org/2001/XMLSchema#string

P304

89-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA013376

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

347

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Hermine

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11267298

http://www.w3.org/2001/XMLSchema#string

P698

12110736

http://www.w3.org/2001/XMLSchema#string